Here’s what’s making health news this morning:
New Bird Flu Study Shows Virus’s Pandemic Potential (WSJ): A paper on genetically altered H5N1 virus in Science is one of two controversial experiments whose planned publication sparked fears it would give terrorists a blueprint for making a biological weapon.
Health Insurance Rebates Seen Totaling $1.1 Billion (WSJ): If the health law goes forward, about 12.8 million people are likely to get refunds as part of a provision in the law requiring companies to spend a set proportion of the money they get from insurance premiums on health care or refund the difference.
Abbott Is Challenging Biotech Drug Copies (WSJ): If the challenge succeeds, less-expensive versions of complex biologic drugs couldn’t go on sale in the U.S. for years, and consumers may never have access to facsimiles of existing treatments such as Abbott’s rheumatoid arthritis therapy Humira, which had $3.4 billion in U.S. sales last year and is projected to be the world’s No. 1-selling drug this year.
Roche Investigated Over Safety (WSJ): Europe’s main medicine regulator said it is investigating Swiss drug giant Roche Holding for failing to properly vet 80,000 reports of possible drug-safety issues received from patients and doctors.
Insurers Seek to Soften Their Image (NY Times): Over the past year, many of the largest insurance companies in the country, including Aetna, Cigna and Humana, have introduced elaborate marketing campaigns to reposition themselves as consumer-friendly health-care companies, not just insurance providers.
Commerce Secretary Bryson Resigns (WSJ): John Bryson resigned Wednesday night, nearly two weeks after being involved in two car crashes in Southern California he said were linked to a seizure, saying his health status could be a distraction
New Bird Flu Study Shows Virus’s Pandemic Potential (WSJ): A paper on genetically altered H5N1 virus in Science is one of two controversial experiments whose planned publication sparked fears it would give terrorists a blueprint for making a biological weapon.
Health Insurance Rebates Seen Totaling $1.1 Billion (WSJ): If the health law goes forward, about 12.8 million people are likely to get refunds as part of a provision in the law requiring companies to spend a set proportion of the money they get from insurance premiums on health care or refund the difference.
Abbott Is Challenging Biotech Drug Copies (WSJ): If the challenge succeeds, less-expensive versions of complex biologic drugs couldn’t go on sale in the U.S. for years, and consumers may never have access to facsimiles of existing treatments such as Abbott’s rheumatoid arthritis therapy Humira, which had $3.4 billion in U.S. sales last year and is projected to be the world’s No. 1-selling drug this year.
Roche Investigated Over Safety (WSJ): Europe’s main medicine regulator said it is investigating Swiss drug giant Roche Holding for failing to properly vet 80,000 reports of possible drug-safety issues received from patients and doctors.
Insurers Seek to Soften Their Image (NY Times): Over the past year, many of the largest insurance companies in the country, including Aetna, Cigna and Humana, have introduced elaborate marketing campaigns to reposition themselves as consumer-friendly health-care companies, not just insurance providers.
Commerce Secretary Bryson Resigns (WSJ): John Bryson resigned Wednesday night, nearly two weeks after being involved in two car crashes in Southern California he said were linked to a seizure, saying his health status could be a distraction
ليست هناك تعليقات:
إرسال تعليق